From:  Targeted therapeutic management of diabetes using phytoconstituents: molecular mechanisms, evidence map (2015–2025), and translational outlook

 Study type distribution.

Study typeNumber of studies (n)Percentage of studies (%)
In vivo6637.3%
In vitro9252.0%
In silico158.5%
Other hybrid methods: human trial, computational, DIA proteomics, HCS42.3%
Total177100.1%

HCS: high-content screening. Due to rounding, the sum of various percentages may not equal 100%.